Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 000435 ( Pmc/Corpus ); précédent : 0004349; suivant : 0004360 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72</title>
<author>
<name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F. A." last="Ennis">F. A. Ennis</name>
</author>
<author>
<name sortKey="Wells, M A" sort="Wells, M A" uniqKey="Wells M" first="M. A." last="Wells">M. A. Wells</name>
</author>
<author>
<name sortKey="Barry, D W" sort="Barry, D W" uniqKey="Barry D" first="D. W." last="Barry">D. W. Barry</name>
</author>
<author>
<name sortKey="Daniel, S" sort="Daniel, S" uniqKey="Daniel S" first="S." last="Daniel">S. Daniel</name>
</author>
<author>
<name sortKey="Manischewitz, J" sort="Manischewitz, J" uniqKey="Manischewitz J" first="J." last="Manischewitz">J. Manischewitz</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">959114</idno>
<idno type="pmc">2496327</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496327</idno>
<idno type="RBID">PMC:2496327</idno>
<date when="1976">1976</date>
<idno type="wicri:Area/Pmc/Corpus">000435</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000435</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72</title>
<author>
<name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F. A." last="Ennis">F. A. Ennis</name>
</author>
<author>
<name sortKey="Wells, M A" sort="Wells, M A" uniqKey="Wells M" first="M. A." last="Wells">M. A. Wells</name>
</author>
<author>
<name sortKey="Barry, D W" sort="Barry, D W" uniqKey="Barry D" first="D. W." last="Barry">D. W. Barry</name>
</author>
<author>
<name sortKey="Daniel, S" sort="Daniel, S" uniqKey="Daniel S" first="S." last="Daniel">S. Daniel</name>
</author>
<author>
<name sortKey="Manischewitz, J" sort="Manischewitz, J" uniqKey="Manischewitz J" first="J." last="Manischewitz">J. Manischewitz</name>
</author>
</analytic>
<series>
<title level="j">Postgraduate Medical Journal</title>
<idno type="ISSN">0032-5473</idno>
<idno type="eISSN">1469-0756</idno>
<imprint>
<date when="1976">1976</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Influenza virus strains A2/Port Chalmers/1/73 (H
<sub>3</sub>
N
<sub>2</sub>
) and B/Hong Kong/5/72 were adapted to mice by serial passage of virus infected mouse lungs. The adapted viruses were used to challenge mice after they had been immunized with serial dilutions of several bivalent vaccines, containing both A/Port Chalmers and B/Hong Kong antigens. Vaccines included both whole virus and split-product preparations disrupted by Tween 80 and ether (ET) or tri-N-butyl phosphate (TBP).</p>
<p>These bivalent vaccines induced antibodies and conferred protection to mice against challenge with approximately 30 LD
<sub>50</sub>
of the adapted A2/Port Chalmers virus. Significant protection against lethality (
<italic>P</italic>
<0·01) was observed in groups of mice which developed haemagglutinin-inhibition antibody titres of ≥1:16 following immunization. Protection was not statistically significant in groups of mice which developed antibody titres of ≤1:8 to the A/Port Chalmers/1/73 virus following immunization with higher dilutions of certain vaccines.</p>
<p>In a similar fashion, current bivalent vaccines containing B/Hong Kong/5/72 stimulated antibodies and conferred significant protection to immunized mice against lethal challenge with the adapted B/Hong Kong virus. Protection was demonstrated against approximately 30 LD
<sub>50</sub>
of adapted virus in groups of mice which developed mean antibodies of ≥1:16. Groups of mice, which developed antibody titres of <1:8 following immunization with certain dilutions of these vaccines, were not significantly protected. These studies confirm and extend observations made with formerly circulating influenza viruses, i.e. immunization with a specific inactivated vaccine in adequate dosage confers protection against a challenge dose of virus lethal to unimmunized mice.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Postgrad Med J</journal-id>
<journal-title>Postgraduate Medical Journal</journal-title>
<issn pub-type="ppub">0032-5473</issn>
<issn pub-type="epub">1469-0756</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">959114</article-id>
<article-id pub-id-type="pmc">2496327</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Influenza Vaccines</subject>
<subj-group>
<subject>Section 2 Mechanisms of Immunity to Influenza in Experimental Animals</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ennis</surname>
<given-names>F. A.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wells</surname>
<given-names>M. A.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barry</surname>
<given-names>D. W.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Daniel</surname>
<given-names>S.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manischewitz</surname>
<given-names>J.</given-names>
</name>
</contrib>
</contrib-group>
<pub-date pub-type="ppub">
<month>06</month>
<year>1976</year>
</pub-date>
<volume>52</volume>
<issue>608</issue>
<fpage>338</fpage>
<lpage>344</lpage>
<abstract>
<p>Influenza virus strains A2/Port Chalmers/1/73 (H
<sub>3</sub>
N
<sub>2</sub>
) and B/Hong Kong/5/72 were adapted to mice by serial passage of virus infected mouse lungs. The adapted viruses were used to challenge mice after they had been immunized with serial dilutions of several bivalent vaccines, containing both A/Port Chalmers and B/Hong Kong antigens. Vaccines included both whole virus and split-product preparations disrupted by Tween 80 and ether (ET) or tri-N-butyl phosphate (TBP).</p>
<p>These bivalent vaccines induced antibodies and conferred protection to mice against challenge with approximately 30 LD
<sub>50</sub>
of the adapted A2/Port Chalmers virus. Significant protection against lethality (
<italic>P</italic>
<0·01) was observed in groups of mice which developed haemagglutinin-inhibition antibody titres of ≥1:16 following immunization. Protection was not statistically significant in groups of mice which developed antibody titres of ≤1:8 to the A/Port Chalmers/1/73 virus following immunization with higher dilutions of certain vaccines.</p>
<p>In a similar fashion, current bivalent vaccines containing B/Hong Kong/5/72 stimulated antibodies and conferred significant protection to immunized mice against lethal challenge with the adapted B/Hong Kong virus. Protection was demonstrated against approximately 30 LD
<sub>50</sub>
of adapted virus in groups of mice which developed mean antibodies of ≥1:16. Groups of mice, which developed antibody titres of <1:8 following immunization with certain dilutions of these vaccines, were not significantly protected. These studies confirm and extend observations made with formerly circulating influenza viruses, i.e. immunization with a specific inactivated vaccine in adequate dosage confers protection against a challenge dose of virus lethal to unimmunized mice.</p>
</abstract>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000435  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000435  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021